Reliq Health Technologies https://www.reliqhealth.com, a global telemedicine company has signed a new contract with their first orthopedic practice in Texas to enable the company to launch their newest iUGO Care platform.
The iUGO Care platform https://iugohealth.com integrates with iUGO Home devices and over 97% of all Bluetooth, Wi-Fi, and SIM card-enabled Durable Medical Equipment (DME). The platform also supports access to telemedicine, chronic care management, wound care, and other services
According to the CDC, there are over 5.7 million arthritis in patients in Texas alone. Leveraging existing Medicare and Medicaid billing codes, orthopedic practices can generate over $500,000 per year in new billings by providing RPM, CCM, PCM, and BHI services to their patients.
Orthopedic specialists using the company’s iUGO Care platform now enables orthopedic specialists to manage their chronic orthopedic patients living with rheumatoid arthritis, osteoarthritis, osteoporosis, etc. and post-operative patients at home.
In another move, Reliq recently announced that they have signed a new contract with a physician practice in Florida that provides clinical services to over 25 Skilled Nursing Facilities (SNF).
The iUGO Care platform will enable physicians who work with SNFs to offer post discharge care to patients and reduce readmissions that can result in significant financial penalties for SNFs.
In February 2021, Reliq, signed a new contract with a nephrology practice in Texas to use the iUGO Care platform to monitor Chronic Kidney Disease (CKD) patients. According to Dr. Lisa Crossley, CEO, Reliq Health, “We are pleased to be able to use the technology to monitor CKD patients and help improve their health outcomes.”
By using the iUGO Care platform, nephrologists can help monitor medication compliance and manage patients’ co-morbidities like diabetes and high blood pressure, to help reduce or prevent further damage to the kidneys. Dr. Crossley expects to have at least 5.000 kidney disease patients on the platform by the end of 2021.